BRIEF published on 07/23/2024 at 17:57, 2 years 1 month ago GUERBET : Nombre d'actions et de droits de vote au 30 juin 2024 Capital Actions AMF Guerbet Droit De Vote
BRIEF published on 07/23/2024 at 17:57, 2 years 1 month ago GUERBET: Number of shares and voting rights as of June 30, 2024 Capital Actions AMF Guerbet Right To Vote
PRESS RELEASE published on 07/23/2024 at 17:52, 2 years 1 month ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 30 juin 2024 Déclaration relative au nombre de droits de vote et d'actions composant le capital de la société conformément à la réglementation financière Capital Déclaration Droits De Vote Réglementation Financière Actions
BRIEF published on 06/24/2024 at 12:06, 2 years 2 months ago GUERBET : Nombre d'actions et de droits de vote au 31 mai 2024 Capital Droits De Vote Actions AMF Guerbet
BRIEF published on 06/24/2024 at 12:06, 2 years 2 months ago GUERBET: Number of shares and voting rights as of May 31, 2024 Voting Rights Capital Actions AMF Guerbet
PRESS RELEASE published on 06/24/2024 at 12:01, 2 years 2 months ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 mai 2024 Publication des droits de vote et actions composant le capital de la société conformément à la réglementation en vigueur Capital Droits De Vote Actions Réglementation Société
BRIEF published on 05/24/2024 at 17:50, 2 years 3 months ago Hugues Lecat Appointed Chairman of the Board of Directors at Guerbet AI Solutions Appointment Medical Imaging Hugues Lecat Guerbet Board
BRIEF published on 05/24/2024 at 17:50, 2 years 3 months ago Hugues Lecat nommé président du conseil d'administration de Guerbet Rendez-vous Hugues Lecat Solutions D'IA Planche Guerbet L'imagerie Médicale
PRESS RELEASE published on 05/24/2024 at 17:45, 2 years 3 months ago Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet. Hugues Lecat appointed Chairman of the Board of Guerbet. Didier Izabel remains as a director. Strategic acceleration and innovative AI solutions in focus Guerbet Medical Imaging Chairman Of The Board Hugues Lecat Didier Izabel
BRIEF published on 05/21/2024 at 12:12, 2 years 3 months ago Nombre d'actions et de droits de vote de Guerbet au 30 avril 2024 Droits De Vote Capital Social Actions Transparence Guerbet
Published on 09/11/2026 at 15:25, 1 hour 26 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 1 hour 51 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 2 hours 21 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 13:58, 2 hours 53 minutes ago BlackBerry Radar Advances Asset Intelligence for Transportation
Published on 09/11/2026 at 13:00, 3 hours 51 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 16:30, 21 minutes ago Belt and Road Summit in Hong Kong welcomes over 6,200 global leaders to explore new business opportunities
Published on 09/11/2026 at 16:00, 51 minutes ago Deutsche Postbank Funding Trust III published semi-annual report
Published on 09/11/2026 at 16:00, 51 minutes ago Form 8.3 - IPConcept (Luxemburg) S.A.: SONNTAG Premium
Published on 09/11/2026 at 15:29, 1 hour 22 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/11/2026 at 15:24, 1 hour 27 minutes ago Form 8.3 - The Vanguard Group, Inc.: Segro PLC
Published on 09/11/2026 at 07:00, 9 hours 51 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 9 hours 51 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 9 hours 51 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 21 hours 21 minutes ago Availability of the 2026 Interim Financial Report
